Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilofexor in Primary Biliary Cholangitis
NCT02943447Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- Dec 2016
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of cilofexor in primary biliary cholangitis (PBC), sponsored by Gilead Sciences. Started Dec 2016; status: terminated.
02
Drugs
cilofexor
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT02943447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943447.